Stool DNA test: pros, cons, and process

    The stool DNA test, also known as Cologuard, is an at-home screening test for colorectal cancer. It tests for blood and DNA changes in the stool, which may indicate colorectal cancer.

    united states mailbox

    Step by step

    1. Place test bracket on toilet bowl
    2. Place kit container in bracket
    3. Sit on toilet and have bowel movement into container
    4. Remove container and scrape stool sample with kit probe
    5. Place sample in tube and set aside
    6. Add enclosed liquid preservative to container; close tightly
    7. Immediately send both tube and container to testing address by mail

    How it works

    • Like FIT, the stool DNA test (Cologuard) detects microscopic amounts of blood in stool, but also looks for certain DNA changes that are found in cancerous tumors or precancerous polyps. 
    • Cells from precancerous and cancerous lesions with certain mutations often shed DNA biomarkers into the stool, where this test can detect them.
    • Because DNA markers may be present in only very small quantities in stool, sensitive laboratory methods are used to detect the markers. The stool DNA test has high detection rates of early-stage colon cancer.

    What are biomarkers?

    Talking to your doctor about screening

    microscope close up

    The pros

    • Easy to use
    • No special changes to diets or medicines
    • No liquids/prep to drink
    • Inexpensive
    • Covered by most insurance
    • Done in privacy of your home
    • Greater accuracy than FIT
    mother at table with young children

    The cons

    • Patients may find test unpleasant to do
    • Has a high false-negative rate, which can leave colon cancer undiagnosed
    • Has a high false-positive rate
    • Does not provide a view of the colon and rectum
    • May miss tumors that bleed in small amount or not at all
    • Tests may result incorrectly in warm climates or with postal delays
    • Must be repeated every year
    • Follow-up colonoscopy after a positive test may not be covered by insurance

    Top resources

    View all resources
    U.S. Representative Terri Sewell of Alabama

    Alliance supports legislation for multi-cancer early detection

    Learn how the Colorectal Cancer Alliance is advocating for the passage of the Nancy Gardner Sewell Multi-Cancer Early Detection Act (HR 2407), a bipartisan bill that ensures immediate Medicare coverage for life-saving cancer detection tests once approved by the FDA.

    Last updated
    The city of Philadelphia

    Alliance adds partners to expand 45+ Reasons campaign

    The Alliance’s 45+ Reasons campaign is part of the Cycles of Impact initiative launched and supported by Independence Blue Cross in 2022 to address the urgent public health issue of colorectal cancer among the Black population.

    Last updated